Liver metastases are a major cause of death from colorectal cancer. Intraarterial therapy
options for colorectal liver metastases include chemoinfusion via a hepatic arterial pump or …

Hepatic metastases of colorectal carcinoma are a leading cause of cancer-related mortality.
Most colorectal liver metastases become refractory to chemotherapy and biologic agents, at …

The majority of patients with advanced colorectal cancer die from hepatic metastases
caused by disease progression; therefore, several novel technologies are in clinical …

Unresectable primary and metastatic liver tumors are a leading cause of cancer mortality
and morbidity. This remains a challenging and key task for every oncologist despite …

Intra-arterial therapies for unresectable hepatic metastases from colorectal cancer include
radioembolization (RE) with yttrium-90 microspheres, transarterial chemoembolization …

Colorectal malignancy is the third most common cancer and one of the prevalent causes of
death globally. Around 20-25% of patients present with metastases at the time of diagnosis …

PURPOSE: To present data for radioembolization with yttrium-90 (90Y) resin microspheres
in patients with colorectal cancer liver metastases in whom currently available therapies had …

Background Metastatic colorectal cancer liver metastases Outcomes after
RadioEmbolization (MORE) was an investigator-initiated case-control study to assess the …

Purpose To investigate the safety, response rate, progression-free and overall survival of
patients with liver metastases treated with 90 Y (glass) radioembolisation in a prospective …

PURPOSE: To determine in a retrospective study the potential benefit on survival outcomes
of radioembolization using yttrium-90 (90Y) resin microspheres in a cohort of patients …